Search filters

List of works by Carmine Carbone

A Case-Matched Gender Comparison Transcriptomic Screen Identifies eIF4E and eIF5 as Potential Prognostic Markers in Male Breast Cancer ⬇️

scientific article published on 16 December 2016

A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma.

scientific article

Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells

scientific article published on 23 May 2013

Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells.

scientific article published on 5 June 2014

An FGFR3 Autocrine Loop Sustains Acquired Resistance to Trastuzumab in Gastric Cancer Patients.

scientific article published on 7 June 2016

An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis.

scientific article

Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer.

scientific article published in February 2018

Anti-VEGF treatment-resistant pancreatic cancers secrete proinflammatory factors that contribute to malignant progression by inducing an EMT cell phenotype.

scientific article

Combined inhibition of IL1, CXCR1/2, and TGFβ signaling pathways modulates in-vivo resistance to anti-VEGF treatment

scientific article published on 15 October 2015

Current Strategies to Overcome Resistance to ALK-Inhibitor Agents

scientific article published on 12 August 2015

EMT and Treatment Resistance in Pancreatic Cancer.

scientific article published on 12 September 2017

Gut microbiome, big data and machine learning to promote precision medicine for cancer

scientific article published on 09 July 2020

HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT.

scientific article published on September 2011

Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer Patients.

scientific article published on 15 March 2017

Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease

scientific article published on 22 August 2019

Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3

scientific article published on 18 September 2019

Induction of immunosuppressive functions and NF-κB by FLIP in monocytes

scientific article published in Nature Communications

Mechanisms of resistance to chemotherapeutic and anti-angiogenic drugs as novel targets for pancreatic cancer therapy.

scientific article published on 30 April 2013

Modulation of pancreatic cancer chemoresistance by inhibition of TAK1

scientific article

Molecular alterations in basal cell carcinoma subtypes

scientific article published on 24 June 2021

Molecular analysis of a male breast cancer patient with prolonged stable disease under mTOR/PI3K inhibitors BEZ235/everolimus.

scientific article published on March 2016

NF-κB as a target for pancreatic cancer therapy.

scientific article published on 23 March 2012

PTEN in Lung Cancer: Dealing with the Problem, Building on New Knowledge and Turning the Game Around

scientific article published on 09 August 2019

Pancreatic Cancer and Obesity: Molecular Mechanisms of Cell Transformation and Chemoresistance

scientific article published on 25 October 2018

Predictive biomarkers for the treatment of resectable esophageal and esophago-gastric junction adenocarcinoma: from hypothesis generation to clinical validation

scientific article published on 16 March 2018

Small Molecule Inhibitors of Microenvironmental Wnt/β-Catenin Signaling Enhance the Chemosensitivity of Acute Myeloid Leukemia

scientific article published on 21 September 2020

TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients

scientific article

Tissue transglutaminase (TG2) is involved in the resistance of cancer cells to the histone deacetylase (HDAC) inhibitor vorinostat.

scientific article

Tissue transglutaminase: a new target to reverse cancer drug resistance

scientific article published on December 2011

Vorinostat Potentiates 5-Fluorouracil/Cisplatin Combination by Inhibiting Chemotherapy-Induced EGFR Nuclear Translocation and Increasing Cisplatin Uptake

scientific article published on 12 June 2019

Paulina is supported by:

About Paulina

Help